Hypoplasia of Pancreatic Islets in Transgenic Mice Expressing Activin Receptor Mutants

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1998 Jul 17

PMID 9664070

Citations 45

Authors

T Yamaoka

C Idehara

M Yano

T Matsushita

T Yamada

S Ii

M Moritani

J Hata

H Sugino

S Noji

M Itakura

Affiliations

Soon will be listed here.

Abstract

Activin, a member of the TGF-beta superfamily, regulates the growth and differentiation of a variety of cell types. Based on the expression of activin in pancreatic rudiments of rat embryos and stimulation of insulin secretion from adult rat pancreatic islets by activin, activin is implicated in the development and function of islets. To examine the significance of activin signaling in the fetal and postnatal development of islets, transgenic mice expressing a dominant negative form of activin receptor (dn-ActR) or a constitutively active form of activin receptor (ActR-T206D) in islets were generated together with the transgenic mice expressing intact activin receptor (intact ActR) as a negative control. Transgenic mice with both dn-ActR and ActR-T206D showed lower survival rates, smaller islet area, and lower insulin content in the whole pancreas with impaired glucose tolerance when compared with transgenic mice with intact ActR or littermates, but they showed the same alpha cell/beta cell ratios as their littermates. In addition to islet hypoplasia, the insulin response to glucose was severely impaired in dn-ActR transgenic mice. It is suggested that a precisely regulated intensity of activin signaling is necessary for the normal development of islets at the stage before differentiation into alpha and beta cells, and that activin plays a role in the postnatal functional maturation of islet beta cells.

Citing Articles

A One-Step, Monolayer Culture and Chemical-Based Approach to Generate Insulin-Producing Cells From Human Adipose-Derived Stem Cells to Mitigate Hyperglycemia in STZ-Induced Diabetic Rats.

Liang R, Zhang K, Chuang M, Lin F, Chen T, Lin J Cell Transplant. 2022; 31:9636897221106995.

PMID: 36002988 PMC: 9421045. DOI: 10.1177/09636897221106995.

Treatment with Soluble Activin Type IIB Receptor Ameliorates Ovariectomy-Induced Bone Loss and Fat Gain in Mice.

Puolakkainen T, Rummukainen P, Pihala-Nieminen V, Ritvos O, Savontaus E, Kiviranta R Calcif Tissue Int. 2022; 110(4):504-517.

PMID: 35024891 PMC: 8927044. DOI: 10.1007/s00223-021-00934-0.

Dual Roles of the Activin Signaling Pathway in Pancreatic Cancer.

Qiu W, Kuo C, Tian Y, Su G Biomedicines. 2021; 9(7).

PMID: 34356885 PMC: 8301451. DOI: 10.3390/biomedicines9070821.

TGF-β Signaling in Pancreatic Islet β Cell Development and Function.

Lee J, Lee J, Rane S Endocrinology. 2020; 162(3).

PMID: 33349851 PMC: 8240135. DOI: 10.1210/endocr/bqaa233.

Nonproliferative and Proliferative Lesions of the Rat and Mouse Endocrine System.

Brandli-Baiocco A, Balme E, Bruder M, Chandra S, Hellmann J, Hoenerhoff M J Toxicol Pathol. 2018; 31(3 Suppl):1S-95S.

PMID: 30158740 PMC: 6108091. DOI: 10.1293/tox.31.1S.

References

Furukawa M, Eto Y, Kojima I . Expression of immunoreactive activin A in fetal rat pancreas. Endocr J. 1995; 42(1):63-8. DOI: 10.1507/endocrj.42.63. View

Slack J . Developmental biology of the pancreas. Development. 1995; 121(6):1569-80. DOI: 10.1242/dev.121.6.1569. View

Yu J, SHAO L, Lemas V, Yu A, Vaughan J, Rivier J . Importance of FSH-releasing protein and inhibin in erythrodifferentiation. Nature. 1987; 330(6150):765-7. DOI: 10.1038/330765a0. View

Alpert S, Hanahan D, Teitelman G . Hybrid insulin genes reveal a developmental lineage for pancreatic endocrine cells and imply a relationship with neurons. Cell. 1988; 53(2):295-308. DOI: 10.1016/0092-8674(88)90391-1. View

Otonkoski T, Andersson S, Knip M, Simell O . Maturation of insulin response to glucose during human fetal and neonatal development. Studies with perifusion of pancreatic isletlike cell clusters. Diabetes. 1988; 37(3):286-91. DOI: 10.2337/diab.37.3.286. View

Totsuka Y, Tabuchi M, Kojima I, Shibai H, Ogata E . A novel action of activin A: stimulation of insulin secretion in rat pancreatic islets. Biochem Biophys Res Commun. 1988; 156(1):335-9. DOI: 10.1016/s0006-291x(88)80845-3. View

Schubert D, Kimura H, LaCorbiere M, Vaughan J, Karr D, Fischer W . Activin is a nerve cell survival molecule. Nature. 1990; 344(6269):868-70. DOI: 10.1038/344868a0. View

Smith J, Price B, Van Nimmen K, Huylebroeck D . Identification of a potent Xenopus mesoderm-inducing factor as a homologue of activin A. Nature. 1990; 345(6277):729-31. DOI: 10.1038/345729a0. View

Thomsen G, Woolf T, Whitman M, Sokol S, Vaughan J, Vale W . Activins are expressed early in Xenopus embryogenesis and can induce axial mesoderm and anterior structures. Cell. 1990; 63(3):485-93. DOI: 10.1016/0092-8674(90)90445-k. View

10.

Hemmati-Brivanlou A, Melton D . A truncated activin receptor inhibits mesoderm induction and formation of axial structures in Xenopus embryos. Nature. 1992; 359(6396):609-14. DOI: 10.1038/359609a0. View

11.

Green J, New H, Smith J . Responses of embryonic Xenopus cells to activin and FGF are separated by multiple dose thresholds and correspond to distinct axes of the mesoderm. Cell. 1992; 71(5):731-9. DOI: 10.1016/0092-8674(92)90550-v. View

12.

Shull M, Ormsby I, Kier A, Pawlowski S, Diebold R, Yin M . Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 1992; 359(6397):693-9. PMC: 3889166. DOI: 10.1038/359693a0. View

13.

Ogawa K, Abe K, Kurosawa N, Kurohmaru M, Sugino H, Takahashi M . Expression of alpha, beta A and beta B subunits of inhibin or activin and follistatin in rat pancreatic islets. FEBS Lett. 1993; 319(3):217-20. DOI: 10.1016/0014-5793(93)80549-a. View

14.

Yasuda H, Inoue K, Shibata H, Takeuchi T, Eto Y, Hasegawa Y . Existence of activin-A in A- and D-cells of rat pancreatic islet. Endocrinology. 1993; 133(2):624-30. DOI: 10.1210/endo.133.2.8344202. View

15.

Shibata H, Yasuda H, Sekine N, Mine T, Totsuka Y, Kojima I . Activin A increases intracellular free calcium concentrations in rat pancreatic islets. FEBS Lett. 1993; 329(1-2):194-8. DOI: 10.1016/0014-5793(93)80220-o. View

16.

Bhushan A, Lin H, Lodish H, Kintner C . The transforming growth factor beta type II receptor can replace the activin type II receptor in inducing mesoderm. Mol Cell Biol. 1994; 14(6):4280-5. PMC: 358794. DOI: 10.1128/mcb.14.6.4280-4285.1994. View

17.

Schulte-Merker S, Smith J, Dale L . Effects of truncated activin and FGF receptors and of follistatin on the inducing activities of BVg1 and activin: does activin play a role in mesoderm induction?. EMBO J. 1994; 13(15):3533-41. PMC: 395257. DOI: 10.1002/j.1460-2075.1994.tb06660.x. View

18.

Gurdon J, Harger P, Mitchell A, Lemaire P . Activin signalling and response to a morphogen gradient. Nature. 1994; 371(6497):487-92. DOI: 10.1038/371487a0. View

19.

Jonsson J, Carlsson L, Edlund T, Edlund H . Insulin-promoter-factor 1 is required for pancreas development in mice. Nature. 1994; 371(6498):606-9. DOI: 10.1038/371606a0. View

20.

Weinhaus A, Poronnik P, Cook D, Tuch B . Insulin secretagogues, but not glucose, stimulate an increase in [Ca2+]i in the fetal rat beta-cell. Diabetes. 1995; 44(1):118-24. DOI: 10.2337/diab.44.1.118. View